Neurodegeneration as an RNA disorder

Progress in Neurobiology

Volumn 99, Issue 3, 2012, Pages 293-315

  Johnson, Rory ^a   Noble, Wendy ^b   Tartaglia, Gian Gaetano ^a   Buckley, Noel J ^b  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; BACE1; HAR1; Huntington's disease; Long non coding RNA; MicroRNA; Mir 124; Mir 132; Mir 9; Neurodegeneration; Neurodegenerative disease; Non coding RNA; Parkinson's disease; REST; SOX2OT; Trinucleotide repeat disorder

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BIOLOGICAL MARKER; CALCIUM; COPPER ZINC SUPEROXIDE DISMUTASE; FUSED IN SARCOMA PROTEIN; HUNTINGTIN; PRESENILIN 1; PRESENILIN 2; RNA BINDING PROTEIN; SMALL INTERFERING RNA; TAR DNA BINDING PROTEIN; TAU PROTEIN; TRINUCLEOTIDE; UNTRANSLATED RNA;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTISENSE THERAPY; BIOINFORMATICS; BRAIN DEVELOPMENT; CELL INTERACTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; DNA REPAIR; DRUG TARGETING; DUCHENNE MUSCULAR DYSTROPHY; EXCITOTOXICITY; GENE MUTATION; GENE REGULATORY NETWORK; GENE TARGETING; GENETIC DISORDER; GLIA; HIGH THROUGHPUT SEQUENCING; HUMAN; HUNTINGTON CHOREA; MAMMAL; MYOTONIC DYSTROPHY; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE CELL EXCITABILITY; NERVE DEGENERATION; NERVE FIBER TRANSPORT; NERVOUS SYSTEM INFLAMMATION; NEUROBIOLOGY; OLIGOMERIZATION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; REVIEW; RNA INTERFERENCE; RNA PROCESSING; SINGLE NUCLEOTIDE POLYMORPHISM; SPINAL MUSCULAR ATROPHY; TRANSCRIPTOMICS; TRINUCLEOTIDE REPEAT; TURNER SYNDROME;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; NEURODEGENERATIVE DISEASES; RNA, UNTRANSLATED; TRANSCRIPTION, GENETIC; TRINUCLEOTIDE REPEATS;

EID: 84869884750     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2012.09.006     Document Type: Review

References (315)

1. The Dutch-Belgian Fragile X Consortium, 1994. Fmr1 knockout mice: a model to study fragile X mental retardation. Cell 78(1), 23-33.
2. The ENCODE, 2004. ENCyclopedia Of DNA Elements Project. Science 306 (5696), 636-640.
3. Amaral P.P., Clark M.B., Gascoigne D.K., Dinger M.E., Mattick J.S. lncRNAdb: a reference database for long noncoding RNAs. Nucleic Acids Research 2010, 39.
4. Amaral P.P., Neyt C., Wilkins S.J., Askarian-Amiri M.E., Sunkin S.M., Perkins A.C., Mattick J.S. Complex architecture and regulated expression of the Sox2ot locus during vertebrate development. RNA 2009, 15(11):2013-2027.
5. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genetics 1999, 23(2):185-188.
6. Annilo T., Kepp K., Laan M. Natural antisense transcript of natriuretic peptide precursor A (NPPA): structural organization and modulation of NPPA expression. BMC Molecular Biology 2009, 10:81.
7. Anthony K., Gallo J.M. Aberrant RNA processing events in neurological disorders. Brain Research 2010, 1338:67-77.
8. Anthony K., Gallo J.M. Aberrant RNA processing events in neurological disorders. Brain Research 2010, 1338:67-77.
9. Aravin A.A., Sachidanandam R., Girard A., Fejes-Toth K., Hannon G.J. Developmentally regulated piRNA clusters implicate MILI in transposon control. Science 2007, 316(5825):744-747.
10. Arisi I., D'Onofrio M., Brandi R., Felsani A., Capsoni S., Drovandi G., Felici G., Weitschek E., Bertolazzi P., Cattaneo A. Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection. Journal of Alzheimer's Disease: JAD 2011, 24(4):721-738.
11. Baas T., Baskin C.R., Diamond D.L., Garcia-Sastre A., Bielefeldt-Ohmann H., Tumpey T.M., Thomas M.J., Carter V.S., Teal T.H., Van Hoeven N., et al. Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics. Journal of Virology 2006, 80(21):10813-10828.
12. Bak M., Silahtaroglu A., Moller M., Christensen M., Rath M.F., Skryabin B., Tommerup N., Kauppinen S. MicroRNA expression in the adult mouse central nervous system. RNA 2008, 14(3):432-444.
13. Banez-Coronel M., Porta S., Kagerbauer B., Mateu-Huertas E., Pantano L., Ferrer I., Guzman M., Estivill X., Marti E. A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity. PLoS Genetics 2012, 8(2):e1002481.
14. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
15. Beers D.R., Henkel F, Zhao W., Wang J., Appel S.H. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(40):15558-15563.
16. Bekris L.M., Yu C.E., Bird T.D., Tsuang D.W. Genetics of Alzheimer disease. Journal of Geriatric Psychiatry and Neurology 2010, 23(4):213-227.
17. Belgard T.G., Marques A.C., Oliver P.L., Abaan H.O., Sirey T.M., Hoerder-Suabedissen A., Garcia-Moreno F., Molnar Z., Margulies E.H., Ponting C.P. A transcriptomic atlas of mouse neocortical layers. Neuron 2011, 71(4):605-616.
18. Bellucci M., Agostini F., Masin M., Tartaglia G.G. Predicting protein associations with long noncoding RNAs. Nature Methods 2011, 8(6):444-445.
19. Bellucci M., Agostini F., Masin M., Tartaglia G.G. Predicting protein associations with long noncoding RNAs. Nature Methods 2011, 8(6):444-445.
20. Beniaminov A., Westhof E., Krol A. Distinctive structures between chimpanzee and human in a brain noncoding RNA. RNA 2008, 14(7):1270-1275.
21. Berger Z., Roder H., Hanna A., Carlson A., Rangachari V., Yue M., Wszolek Z., Ashe K., Knight J., Dickson D., et al. Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. Journal of Neuroscience 2007, 27(14):3650-3662.
22. Bernard D., Prasanth K.V., Tripathi V., Colasse S., Nakamura T., Xuan Z., Zhang M.Q., Sedel F., Jourdren L., Coulpier F., et al. A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. The EMBO Journal 2010, 29(18):3082-3093.
23. Bilen J., Liu N., Burnett B.G., Pittman R.N., Bonini N.M. MicroRNA pathways modulate polyglutamine-induced neurodegeneration. Molecular Cell 2006, 24(1):157-163.
24. Blackshaw S., Harpavat S., Trimarchi J., Cai L., Huang H., Kuo W.P., Weber G., Lee K., Fraioli R.E., Cho S.H., et al. Genomic analysis of mouse retinal development. PLoS Biology 2004, 2(9):E247.
25. Bond A.M., Vangompel M.J., Sametsky E.A., Clark M.F., Savage J.C., Disterhoft J.F., Kohtz J.D. Balanced gene regulation by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitry. Nature Neuroscience 2009, 12(8):1020-1027.
26. Bossers K., Wirz K.T., Meerhoff G.F., Essing A.H., van Dongen J.W., Houba P., Kruse C.G., Verhaagen J., Swaab D.F. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease. Brain: A Journal of Neurology 2010, 133(Pt 12):3699-3723.
27. Bothwell M., Giniger E. Alzheimer's disease: neurodevelopment converges with neurodegeneration. Cell 2000, 102(3):271-273.
28. Bouchard M., Grote D., Craven S.E., Sun Q., Steinlein P., Busslinger M. Identification of Pax2-regulated genes by expression profiling of the mid-hindbrain organizer region. Development 2005, 132(11):2633-2643.
29. Bove J., Martinez-Vicente M., Vila M. Fighting neurodegeneration with rapamycin: mechanistic insights. Nature Reviews Neuroscience 2011, 12(8):437-452.
30. Braak H., Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiology of Aging 1995, 16(3):278-284. discussion pp, 271-278.
31. Brook J.D., McCurrach M.E., Harley H.G., Buckler A.J., Church D., Aburatani H., Hunter K., Stanton V.P., Thirion J.P., Hudson T., et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992, 68(4):799-808.
32. Brunden K.R., Zhang B., Carroll J., Yao Y., Potuzak J.S., Hogan A.M., Iba M., James M.J., Xie S.X., Ballatore C., et al. Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy. Journal of Neuroscience 2010, 30(41):13861-13866.
33. Bustin S.A. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. Journal of Molecular Endocrinology 2002, 29(1):23-39.
34. Cabili M.N., Trapnell C., Goff L., Koziol M., Tazon-Vega B., Regev A., Rinn J.L. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes & Development 2011, 25(18):1915-1927.
35. Campuzano V., Montermini L., Molto M.D., Pianese L., Cossee M., Cavalcanti F., Monros E., Rodius F., Duclos F., Monticelli A., et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996, 271(5254):1423-1427.
36. Carango P., Noble J.E., Marks H.G., Funanage V.L. Absence of myotonic dystrophy protein kinase (DMPK) mRNA as a result of a triplet repeat expansion in myotonic dystrophy. Genomics 1993, 18(2):340-348.
37. Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., et al. The transcriptional landscape of the mammalian genome. Science 2005, 309(5740):1559-1563.
38. Carriedo S.G., Sensi S.L., Yin H.Z., Weiss J.H. AMPA exposures induce mitochondrial Ca(2+) overload and ROS generation in spinal motor neurons in vitro. Journal of Neuroscience 2000, 20(1):240-250.
39. Cattaneo E., Zuccato C., Tartari M. Normal huntingtin function: an alternative approach to Huntington's disease. Nature Reviews Neuroscience 2005, 6(12):919-930.
40. Cesana M., Cacchiarelli D., Legnini I., Santini T., Sthandier O., Chinappi M., Tramontano A., Bozzoni I. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011, 147(2):358-369.
41. Cho D.H., Thienes C.P., Mahoney S.E., Analau E., Filippova G.N., Tapscott S.J. Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Molecular Cell 2005, 20(3):483-489.
42. Chodroff R.A., Goodstadt L., Sirey T.M., Oliver P.L., Davies K.E., Green E.D., Molnar Z., Ponting C.P. Long noncoding RNA genes: conservation of sequence and brain expression among diverse amniotes. Genome Biology 2010, 11(7):R72.
43. Christov C.P., Trivier E., Krude T. Noncoding human Y RNAs are overexpressed in tumours and required for cell proliferation. British Journal of Cancer 2008, 98(5):981-988.
44. Chung D.W., Rudnicki D.D., Yu L., Margolis R.L. A natural antisense transcript at the Huntington's disease repeat locus regulates HTT expression. Human Molecular Genetics 2011, 20(17):3467-3477.
45. Clemson C.M., Hutchinson J.N., Sara S.A., Ensminger A.W., Fox A.H., Chess A., Lawrence J.B. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Molecular Cell 2009, 33(6):717-726.
46. Cohen T.J., Lee V.M., Trojanowski J.Q. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends in Molecular Medicine 2011.
47. Conaco C., Otto S., Han J.J., Mandel G. Reciprocal actions of REST and a microRNA promote neuronal identity. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(7):2422-2427.
48. Cook K.B., Kazan H., Zuberi K., Morris Q., Hughes T.R. RBPDB: a database of RNA-binding specificities. Nucleic Acids Research 2010.
49. Coppede F., Migliore L. DNA repair in premature aging disorders and neurodegeneration. Current Aging Science 2010, 3(1):3-19.
50. Couthouis J., Hart M.P., Shorter J., Dejesus-Hernandez M., Erion R., Oristano R., Liu A.X., Ramos D., Jethava N., Hosangadi D., et al. Feature Article: From the Cover: A yeast functional screen predicts new candidate ALS disease genes. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(52):20881-20890.
51. Crosiers D., Theuns J., Cras P., Van Broeckhoven C. Parkinson disease: Insights in clinical, genetic and pathological features of monogenic disease subtypes. Journal of Chemical Neuroanatomy 2011.
52. Danesh A., Cameron C.M., Leon A.J., Ran L., Xu L., Fang Y., Kelvin A.A., Rowe T., Chen H., Guan Y., et al. Early gene expression events in ferrets in response to SARS coronavirus infection versus direct interferon-alpha2b stimulation. Virology 2011, 409(1):102-112.
53. Daniele N., Richard I., Bartoli M. Ins and outs of therapy in limb girdle muscular dystrophies. The International Journal of Biochemistry & Cell Biology 2007, 39(9):1608-1624.
54. Dansithong W., Paul S., Comai L., Reddy S. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1. The Journal of Biological Chemistry 2005, 280(7):5773-5780.
55. Dash P.K., Hochner B., Kandel E.R. Injection of the cAMP-responsive element into the nucleus of Aplysia sensory neurons blocks long-term facilitation. Nature 1990, 345(6277):718-721.
56. Davis B.M., McCurrach M.E., Taneja K.L., Singer R.H., Housman D.E. Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proceedings of the National Academy of Sciences of the United States of America 1997, 94(14):7388-7393.
57. Davranche A., Aviolat H., Zeder-Lutz G., Busso D., Altschuh D., Trottier Y., Klein F.A. Huntingtin affinity for partners is not changed by polyglutamine length: aggregation itself triggers aberrant interactions. Human Molecular Genetics 2011, 20(14):2795-2806.
58. De Coo I.F., Renier W.O., Ruitenbeek W., Ter Laak H.J., Bakker M., Schagger H., Van Oost B.A., Smeets H.J. A 4-base pair deletion in the mitochondrial cytochrome b gene associated with parkinsonism/MELAS overlap syndrome. Annals of Neurology 1999, 45(1):130-133.
59. de la Monte S.M., Luong T., Neely T.R., Robinson D., Wands J.R. Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease. Laboratory Investigation 2000, 80(8):1323-1335.
60. de Mezer M., Wojciechowska M., Napierala M., Sobczak K., Krzyzosiak W.J. Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference. Nucleic Acids Research 2011, 39(9):3852-3863.
61. De Vos K.J., Grierson A.J., Ackerley S., Miller C.C. Role of axonal transport in neurodegenerative diseases. Annual Review of Neuroscience 2008, 31:151-173.
62. De Vos K.J., Morotz G.M., Stoica R., Tudor E.L., Lau K.F., Ackerley S., Warley A., Shaw C.E., Miller C.C. VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Human Molecular Genetics 2011.
63. del Fresno C., Garcia-Rio F., Gomez-Pina V., Soares-Schanoski A., Fern√√ndez-Ru√≠z I., Jurado T., Kajiji T., Shu C., Marin E., Gutierrez del Arroyo A., et al. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. The Journal of Immunology 2009, 182(10):6494-6507.
64. Del-Favero J., Krols L., Michalik A., Theuns J., Lofgren A., Goossens D., Wehnert A., Van den Bossche D., Van Zand K., Backhovens H., et al. Molecular genetic analysis of autosomal dominant cerebellar ataxia with retinal degeneration (ADCA type II) caused by CAG triplet repeat expansion. Human Molecular Genetics 1998, 7(2):177-186.
65. Derrien T., Johnson R., Bussotti G., Tanzer A., Djebali S., Tilgner H., Guernec, Martin D., Merkel A., Gonzalez D., et al. The GENCODE v7 catalogue human long non-coding RNAs: Analysis of their gene structure, evolution and expression. Genome Research 2012, 22(9):1775-1789.
66. DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P., Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997, 277(5334):1990-1993.
67. Dinger M.E., Amaral P.P., Mercer T.R., Pang K.C., Bruce S.J., Gardiner B.B., Askarian-Amiri M.E., Ru K., Solda G., Simons C., et al. Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Research 2008, 18(9):1433-1445.
68. Dinger M.E., Pang K.C., Mercer T.R., Mattick J.S. PLoS Computational Biology. Differentiating protein-coding and noncoding RNA: challenges and ambiguities 2008, 4(11):e1000176.
69. Dobson C.M. Protein misfolding, evolution and disease. Trends in Biochemical Sciences 1999, 24(9):329-332.
70. Dompierre J.P., Godin J.D., Charrin B.C., Cordelieres F.P., King S.J., Humbert S., Saudou F. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. Journal of Neuroscience 2007, 27(13):3571-3583.
71. Doxakis E. Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. The Journal of Biological Chemistry 2010, 285(17):12726-12734.
72. Dragatsis I., Levine M.S., Zeitlin S. Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nature Genetics 2000, 26(3):300-306.
73. Dufty B.M., Warner L.R., Hou S.T., Jiang S.X., Gomez-Isla T., Leenhouts K.M., Oxford J.T., Feany M.B., Masliah E., Rohn T.T. Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation. The American Journal of Pathology 2007, 170(5):1725-1738.
74. Edbauer D., Neilson J.R., Foster K.A., Wang C.F., Seeburg D.P., Batterton M.N., Tada T., Dolan B.M., Sharp P.A., Sheng M. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 2010, 65(3):373-384.
75. Edlund T., Jessell T.M. Progression from extrinsic to intrinsic signaling in cell fate specification: a view from the nervous system. Cell 1999, 96(2):211-224.
76. Edmonds R.D., Vodovotz Y., Lagoa C., Dutta-Moscato J., Yang Y., Fink M.P., Levy R.M., Prince J.M., Kaczorowski D.J., Tseng G.C., et al. Transcriptomic response of murine liver to severe injury and hemorrhagic shock: A dual platform microarray analysis. Physiological Genomics 2011.
77. Elbaz A., Ross O.A., Ioannidis J.P., Soto-Ortolaza A.I., Moisan F., Aasly J., Annesi G., Bozi M., Brighina L., Chartier-Harlin M.C., et al. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Annals of Neurology 2011, 69(5):778-792.
78. Everett C.M., Wood N.W. Trinucleotide repeats and neurodegenerative disease. Brain: A Journal of Neurology 2004, 127(Pt 11):2385-2405.
79. Faghihi M.A., Modarresi F., Khalil A.M., Wood D.E., Sahagan B.G., Morgan T.E., Finch C.E., St Laurent G.3rd, Kenny P.J., Wahlestedt C. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nature Medicine 2008, 14(7):723-730.
80. Feng J., Bi C., Clark B.S., Mady R., Shah P., Kohtz J.D. The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes & Development 2006, 20(11):1470-1484.
81. Forner F., Furlan S., Salvatori S. Mass spectrometry analysis of complexes formed by myotonic dystrophy protein kinase (DMPK). Biochimica et Biophysica Acta 2010, 1804(6):1334-1341.
82. Gadad B.S., Britton G.B., Rao K.S. Targeting oligomers in neurodegenerative disorders: lessons from alpha-synuclein, tau, and amyloid-beta peptide. Journal of Alzheimer's Disease 2011, 24(Suppl. 2):223-232.
83. Gallo J.M., Noble W., Martin T.R. RNA and protein-dependent mechanisms in tauopathies: consequences for therapeutic strategies. Cellular and Molecular Life Sciences: CMLS 2007, 64(13):1701-1714.
84. Galtier N., Duret L. Adaptation or biased gene conversion? Extending the null hypothesis of molecular evolution. Trends in Genetics: TIG 2007, 23(6):273-277.
85. Garber M., Grabherr M.G., Guttman M., Trapnell C. Computational methods for transcriptome annotation and quantification using RNA-seq. Nature Methods 2011, 8(6):469-477.
86. Garwood C.J., Pooler A.M., Atherton J., Hanger D.P., Noble W. Astrocytes are important mediators of Abeta-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death and Disease 2011, 2:e167.
87. Geekiyanage H., Chan C. MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer's disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2011, 31(41):14820-14830.
88. Ghose J., Sinha M., Das E., Jana N.R., Bhattacharyya N.P. Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington's disease. PLoS One 2011, 6(8):e23837.
89. Gibson G.E., Karuppagounder S.S., Shi Q. Oxidant-induced changes in mitochondria and calcium dynamics in the pathophysiology of Alzheimer's disease. Annals of New York Academy of Science 2008, 1147:221-232.
90. Gordon F.E., Nutt C.L., Cheunsuchon P., Nakayama Y., Provencher K.A., Rice K.A., Zhou Y., Zhang X., Klibanski A. Increased expression of angiogenic genes in the brains of mouse meg3-null embryos. Endocrinology 2010, 151(6):2443-2452.
91. Gredilla R., Weissman L., Yang J.L., Bohr V.A., Stevnsner T. Mitochondrial base excision repair in mouse synaptosomes during normal aging and in a model of Alzheimer's disease. Neurobiology of Aging 2010.
92. Grilli M., Ferrari Toninelli G., Uberti D., Spano P., Memo M. Alzheimer's disease linking neurodegeneration with neurodevelopment. Functional Neurology 2003, 18(3):145-148.
93. Grosskreutz J., Van Den Bosch L., Keller B.U. Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium 2010, 47(2):165-174.
94. Guillemot F. Cell fate specification in the mammalian telencephalon. Progress in Neurobiology 2007, 83(1):37-52.
95. Guillemot F., Molnar Z., Tarabykin V., Stoykova A. Molecular mechanisms of cortical differentiation. The European Journal of Neuroscience 2006, 23(4):857-868.
96. Gupta-Rossi N., Le Bail O., Gonen H., Brou C., Logeat F., Six E., Ciechanover A., Israel A. Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. Journal of Biological Chemistry 2001, 276(37):34371-34378.
97. Guttman M., Amit I., Garber M., French C., Lin M.F., Feldser D., Huarte M., Zuk O., Carey B.W., Cassady J.P., et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009, 458(7235):223-227.
98. Guttman M., Donaghey J., Carey B.W., Garber M., Grenier J.K., Munson G., Young G., Lucas A.B., Ach R., Bruhn L., et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 2011, 477(7364):295-300.
99. Hagiwara H., Yorifuji H., Sato-Yoshitake R., Hirokawa N. Competition between motor molecules (kinesin and cytoplasmic dynein) and fibrous microtubule-associated proteins in binding to microtubules. Journal of Biological Chemistry 1994, 269(5):3581-3589.
100. Hamma T., Ferre-D'Amare A.R. The box H/ACA ribonucleoprotein complex: interplay of RNA and protein structures in post-transcriptional RNA modification. The Journal of Biological Chemistry 2010, 285(2):805-809.
101. Hampton D.W., Webber D.J., Bilican B., Goedert M., Spillantini M.G., Chandran S. Cell-mediated neuroprotection in a mouse model of human tauopathy. Journal of Neuroscience 2010, 30(30):9973-9983.
102. Hanger D.P., Seereeram A., Noble W. Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease. Expert Review of Neurotherapeutics 2009, 9(11):1647-1666.
103. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A., et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature Genetics 2009, 41(10):1088-1093.
104. Hebert S.S., Horre K., Nicolai L., Papadopoulou A.S., Mandemakers W., Silahtaroglu A.N., Kauppinen S., Delacourte A., De Strooper B. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(17):6415-6420.
105. Herman A.M., Khandelwal P.J., Stanczyk B.B., Rebeck G.W., Moussa C.E. beta-Amyloid triggers ALS-associated TDP-43 pathology in AD models. Brain Research 2011, 1386:191-199.
106. Hetman M., Vashishta A., Rempala G. Neurotoxic mechanisms of DNA damage: focus on transcriptional inhibition. Journal of Neurochemistry 2010, 114(6):1537-1549.
107. Hickman S.E., Allison E.K., El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. Journal of Neuroscience 2008, 28(33):8354-8360.
108. Holmes S.E., O'Hearn E.E., McInnis M.G., Gorelick-Feldman D.A., Kleiderlein J.J., Callahan C., Kwak N.G., Ingersoll-Ashworth R.G., Sherr M., Sumner A.J., et al. Expansion of a novel CAG trinucleotide repeat in the 5' region of PPP2R2B is associated with SCA12. Nature Genetics 1999, 23(4):391-392.
109. Holtzman D.M., Morris J.C., Goate A.M. Alzheimer's disease: the challenge of the second century. Science Translational Medicine 2011, 3(77):77sr1.
110. Huang M., Huang T., Xiang Y., Xie Z., Chen Y., Yan R., Xu J., Cheng L. Ptf1a, Lbx1 and Pax2 coordinate glycinergic and peptidergic transmitter phenotypes in dorsal spinal inhibitory neurons. Developmental Biology 2008, 322(2):394-405.
111. Impey S., McCorkle S.R., Cha-Molstad H., Dwyer J.M., Yochum G.S., Boss J.M., McWeeney S., Dunn J.J., Mandel G., Goodman R.H. Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 2004, 119(7):1041-1054.
112. Ishii N., Ozaki K., Sato H., Mizuno H., Saito S., Takahashi A., Miyamoto Y., Ikegawa S., Kamatani N., Hori M., et al. Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. Journal of Human Genetics 2006, 51(12):1087-1099.
113. Jackson A.L., Bartz S.R., Schelter J., Kobayashi S.V., Burchard J., Mao M., Li B., Cavet G., Linsley P.S. Expression profiling reveals off-target gene regulation by RNAi. Nature Biotechnology 2003, 21(6):635-637.
114. Jellinger K.A. Recent advances in our understanding of neurodegeneration. Journal of Neural Transmission 2009, 116(9):1111-1162.
115. Jeppesen D.K., Bohr V.A., Stevnsner T. DNA repair deficiency in neurodegeneration. Progress in Neurobiology 2011, 94(2):166-200.
116. Jia H., Osak M., Bogu G.K., Stanton L.W., Johnson R., Lipovich L. Genome-wide computational identification and manual annotation of human long noncoding RNA genes. RNA 2010, 16(8):1478-1487.
117. Johnson R. Long non-coding RNAs in Huntington's disease neurodegeneration. Neurobiology of Disease 2011.
118. Johnson R., Richter N., Jauch R., Gaughwin P.M., Zuccato C., Cattaneo E., Stanton L.W. The Human Accelerated Region 1 noncoding RNA is repressed by REST in Huntington's disease. Physiological Genomics 2010.
119. Johnson R., Samuel J., Ng C.K., Jauch R., Stanton L.W., Wood I.C. Evolution of the vertebrate gene regulatory network controlled by the transcriptional repressor REST. Molecular Biology and Evolution 2009, 26(7):1491-1507.
120. Johnson R., Teh C.H., Jia H., Vanisri R.R., Pandey T., Lu Z.H., Buckley N.J., Stanton L.W., Lipovich L. Regulation of neural macroRNAs by the transcriptional repressor REST. RNA 2009, 15(1):85-96.
121. Johnson R., Zuccato C., Belyaev N.D., Guest D.J., Cattaneo E., Buckley N.J. A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiology of Disease 2008, 29(3):438-445.
122. Junn E., Lee K.W., Jeong B.S., Chan T.W., Im J.Y., Mouradian M.M. Repression of alpha-synuclein expression and toxicity by microRNA-7. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(31):13052-13057.
123. Kalbfuss B., Mabon S.A., Misteli T. Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17. The Journal of Biological Chemistry 2001, 276(46):42986-42993.
124. Kalsotra A., Xiao X., Ward A.J., Castle J.C., Johnson J.M., Burge C.B., Cooper T.A. A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(51):20333-20338.
125. Kanadia R.N., Johnstone K.A., Mankodi A., Lungu C., Thornton C.A., Esson D., Timmers A.M., Hauswirth W.W., Swanson M.S. A muscleblind knockout model for myotonic dystrophy. Science 2003, 302(5652):1978-1980.
126. Kapranov P., St Laurent G., Raz T., Ozsolak F., Reynolds C.P., Sorensen P.H., Reaman G., Milos P., Arceci R.J., Thompson J.F., et al. The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA. BMC Biology 2010, 8:149.
127. Katayama S., Tomaru Y., Kasukawa T., Waki K., Nakanishi M., Nakamura M., Nishida H., Yap C.C., Suzuki M., Kawai J., et al. Antisense transcription in the mammalian transcriptome. Science 2005, 309(5740):1564-1566.
128. Kawahara Y., Ito K., Sun H., Aizawa H., Kanazawa I., Kwak S. Glutamate receptors: RNA editing and death of motor neurons. Nature 2004, 427(6977):801.
129. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003, 300(5618):486-489.
130. Kelly T.K., De Carvalho D.D., Jones P.A. Epigenetic modifications as therapeutic targets. Nature Biotechnology 2010, 28(10):1069-1078.
131. Khandelwal P.J., Herman A.M., Moussa C.E. Inflammation in the early stages of neurodegenerative pathology. Journal of Neuroimmunology 2011.
132. Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet 2011, 377(9769):942-955.
133. Kim J., Inoue K., Ishii J., Vanti W.B., Voronov S.V., Murchison E., Hannon G., Abeliovich A. A MicroRNA feedback circuit in midbrain dopamine neurons. Science 2007, 317(5842):1220-1224.
134. Kim T.K., Hemberg M., Gray J.M., Costa A.M., Bear D.M., Wu J., Harmin D.A., Laptewicz M., Barbara-Haley K., Kuersten S., et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 2010, 465(7295):182-187.
135. King M.C., Wilson A.C. Evolution at two levels in humans and chimpanzees. Science 1975, 188(4184):107-116.
136. Kisby G.E., Milne J., Sweatt C. Evidence of reduced DNA repair in amyotrophic lateral sclerosis brain tissue. Neuroreport 1997, 8(6):1337-1340.
137. Klein M.E., Lioy D.T., Ma L., Impey S., Mandel G., Goodman R.H. Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nature Neuroscience 2007, 10(12):1513-1514.
138. Knowles D.G., McLysaght A. Recent de novo origin of human protein-coding genes. Genome Research 2009, 19(10):1752-1759.
139. Komine Y., Nakamura K., Katsuki M., Yamamori T. Novel transcription factor zfh-5 is negatively regulated by its own antisense RNA in mouse brain. Molecular and Cellular Neurosciences 2006, 31(2):273-283.
140. Kong L., Zhang Y., Ye Z.Q., Liu X.Q., Zhao S.Q., Wei L., Gao G. CPC: assess the protein-coding potential of transcripts using sequence features and support vector machine. Nucleic Acids Research 2007, 35(Web Server issue):W345-W349.
141. Koob M.D., Moseley M.L., Schut L.J., Benzow K.A., Bird T.D., Day J.W., Ranum L.P. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nature Genetics 1999, 21(4):379-384.
142. Korneev S.A., Korneeva E.I., Lagarkova M.A., Kiselev S.L., Critchley G., O'Shea M. Novel noncoding antisense RNA transcribed from human anti-NOS2A locus is differentially regulated during neuronal differentiation of embryonic stem cells. RNA 2008, 14(10):2030-2037.
143. Korneev S.A., Park J.H., O'Shea M. Neuronal expression of neural nitric oxide synthase (nNOS) protein is suppressed by an antisense RNA transcribed from an NOS pseudogene. The Journal of Neuroscience 1999, 19(18):7711-7720.
144. Korneev S.A., Straub V., Kemenes I., Korneeva E.I., Ott S.R., Benjamin P.R., O'Shea M. Timed and targeted differential regulation of nitric oxide synthase (NOS) and anti-NOS genes by reward conditioning leading to long-term memory formation. The Journal of Neuroscience 2005, 25(5):1188-1192.
145. Krichevsky A.M., King K.S., Donahue C.P., Khrapko K., Kosik K.S. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 2003, 9(10):1274-1281.
146. Kwan K.Y., Sestan N., Anton E.S. Transcriptional co-regulation of neuronal migration and laminar identity in the neocortex. Development 2012, 139(9):1535-1546.
147. La Spada A.R., Fu Y.H., Sopher B.L., Libby R.T., Wang X., Li L.Y., Einum D.D., Huang J., Possin D.E., Smith A.C., et al. Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7. Neuron 2001, 31(6):913-927.
148. La Spada A.R., Taylor J.P. Polyglutamines placed into context. Neuron 2003, 38(5):681-684.
149. Ladd P.D., Smith L.E., Rabaia N.A., Moore J.M., Georges S.A., Hansen R.S., Hagerman R.J., Tassone F., Tapscott S.J., Filippova G.N. An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Human Molecular Genetics 2007, 16(24):3174-3187.
150. Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., Tuschl T. Identification of tissue-specific microRNAs from mouse. Current Biology: CB 2002, 12(9):735-739.
151. Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B., et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nature Genetics 2009, 41(10):1094-1099.
152. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., Pfeffer S., Rice A., Kamphorst A.O., Landthaler M., et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129(7):1401-1414.
153. Lapierre J., Salomon W., Cardia J., Bulock K., Lam J.T., Stanney W.J., Ford G., Smith-Anzures B., Woolf T., Kamens J., et al. Potent and systematic RNAi mediated silencing with single oligonucleotide compounds. RNA (New York, NY) 2011, 17(6):1032-1037.
154. Lastres-Becker I., Brodesser S., Lutjohann D., Azizov M., Buchmann J., Hintermann E., Sandhoff K., Schurmann A., Nowock J., Auburger G. Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice. Human Molecular Genetics 2008, 17(10):1465-1481.
155. Lastres-Becker I., Rub U., Auburger G. Spinocerebellar ataxia 2 (SCA2). Cerebellum 2008, 7(2):115-124.
156. Latos P.A., Barlow D.P. Regulation of imprinted expression by macro non-coding RNAs. RNA Biology 2009, 6(2):100-106.
157. Le Roy F., Charton K., Lorson C.L., Richard I. RNA-targeting approaches for neuromuscular diseases. Trends in Molecular Medicine 2009, 15(12):580-591.
158. Lee H.J., Khoshaghideh F., Patel S., Lee S.J. Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2004, 24(8):1888-1896.
159. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75(5):843-854.
160. Lee S.T., Chu K., Im W.S., Yoon H.J., Im J.Y., Park J.E., Park K.H., Jung K.H., Lee S.K., Kim M., et al. Altered microRNA regulation in Huntington's disease models. Experimental Neurology 2011, 227(1):172-179.
161. Lee Y., Samaco R.C., Gatchel J.R., Thaller C., Orr H.T., Zoghbi H.Y. miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nature Neuroscience 2008, 11(10):1137-1139.
162. Leissring M.A., Akbari Y., Fanger C.M., Cahalan M.D., Mattson M.P., LaFerla F.M. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. Journal of Cell Biology 2000, 149(4):793-798.
163. Lemon, S.M. and Threats, I. o. M. F. o. M., 2007. Global infectious disease surveillance and detection: assessing the challenges-finding solutions: workshop summary: National Academies Press %@ 9780309111140.
164. Leung K.N., Vallero R.O., DuBose A.J., Resnick J.L., LaSalle J.M. Imprinting regulates mammalian snoRNA-encoding chromatin decondensation and neuronal nucleolar size. Human Molecular Genetics 2009, 18(22):4227-4238.
165. Lewejohann L., Skryabin B.V., Sachser N., Prehn C., Heiduschka P., Thanos S., Jordan U., Dell'Omo G., Vyssotski A.L., Pleskacheva M.G., et al. Role of a neuronal small non-messenger RNA: behavioural alterations in BC1 RNA-deleted mice. Behavioural Brain Research 2004, 154(1):273-289.
166. Li L.B., Yu Z., Teng X., Bonini N.M. RNA toxicity is a component of ataxin-3 degeneration in Drosophila. Nature 2008, 453(7198):1107-1111.
167. Li Y., Zhou X., John St., Wong M.A.R. D.T.W. RNA Profiling of Cell-free Saliva Using Microarray Technology. Journal of Dental Research 2004, 83(3):199-203.
168. Lill C.M., Abel O., Bertram L., Al-Chalabi A. Keeping up with genetic discoveries in amyotrophic lateral sclerosis: the ALSoD and ALSGene databases. Amyotrophic Lateral Sclerosis 2011, 12(4):238-249.
169. Lim L.P., Lau N.C., Garrett-Engele P., Grimson A., Schelter J.M., Castle J., Bartel D.P., Linsley P.S., Johnson J.M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433(7027):769-773.
170. Lin C.L., Bristol L.A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L., Rothstein J.D. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998, 20(3):589-602.
171. Lipovich L., Johnson R., Lin C.Y. MacroRNA underdogs in a microRNA world: evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNA. Biochimica et Biophysica Acta 2010, 1799(9):597-615.
172. Lovell M.A., Xie C., Markesbery W.R. Decreased base excision repair and increased helicase activity in Alzheimer's disease brain. Brain Research 2000, 855(1):116-123.
173. Luheshi L.M., Tartaglia G.G., Brorsson A.C., Pawar A.P., Watson I.E., Chiti F., Vendruscolo M., Lomas D.A., Dobson C.M., Crowther D.C. Systematic in vivo analysis of the intrinsic determinants of amyloid Beta pathogenicity. PLoS Biology 2007, 5(11):e290.
174. Lunkes A., Lindenberg K.S., Ben-Haiem L., Weber C., Devys D., Landwehrmeyer G.B., Mandel J.L., Trottier Y. Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Molecular Cell 2002, 10(2):259-269.
175. Machuy N., Thiede B., Rajalingam K., Dimmler C., Thieck O., Meyer T.F., Rudel T. A global approach combining proteome analysis and phenotypic screening with RNA interference yields novel apoptosis regulators. Molecular & Cellular Proteomics 2005, 4(1):44-55.
176. Makeyev E.V., Zhang J., Carrasco M.A., Maniatis T. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Molecular Cell 2007, 27(3):435-448.
177. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S.W., et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87(3):493-506.
178. Manji S.S., Sorensen B.S., Klockars T., Lam T., Hutchison W., Dahl H.H. Molecular characterization and expression of maternally expressed gene 3 (Meg3/Gtl2) RNA in the mouse inner ear. Journal of Neuroscience Research 2006, 83(2):181-190.
179. Margolis R.L., O'Hearn E., Rosenblatt A., Willour V., Holmes S.E., Franz M.L., Callahan C., Hwang H.S., Troncoso J.C., Ross C.A. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion. Annals of Neurology 2001, 50(6):373-380.
180. Marsh J.L., Walker H., Theisen H., Zhu Y.Z., Fielder T., Purcell J., Thompson L.M. Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila. Human Molecular Genetics 2000, 9(1):13-25.
181. Martianov I., Ramadass A., Serra Barros A., Chow N., Akoulitchev A. Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature 2007, 445(7128):666-670.
182. Martignetti J.A., Brosius J. BC200 RNA: a neural RNA polymerase III product encoded by a monomeric Alu element. Proceedings of the National Academy of Sciences of the United States of America 1993, 90(24):11563-11567.
183. Martin L.J. Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration. Reviews in Neuroscience 2007, 18(2):115-136.
184. Mattick J.S. Challenging the dogma: the hidden layer of non-protein-coding RNAs in complex organisms. BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology 2003, 25(10):930-939.
185. Mattick J.S. RNA regulation: a new genetics?. Nature Reviews. Genetics 2004, 5(4):316-323.
186. Mattick J.S. The genetic signatures of noncoding RNAs. PLoS Genetics 2009, 5(4):e1000459.
187. McBride J.L., Pitzer M.R., Boudreau R.L., Dufour B., Hobbs T., Ojeda S.R., Davidson B.L. Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease. Molecular Therapy: The Journal of the American Society of Gene Therapy 2011, 19(12):2152-2162.
188. Mehler M.F., Mattick J.S. Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease. Physiological Reviews 2007, 87(3):799-823.
189. Mercer T.R., Dinger M.E., Sunkin S.M., Mehler M.F., Mattick J.S. Specific expression of long noncoding RNAs in the mouse brain. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(2):716-721.
190. Mercer T.R., Qureshi I.A., Gokhan S., Dinger M.E., Li G., Mattick J.S., Mehler M.F. Long noncoding RNAs in neuronal-glial fate specification and oligodendrocyte lineage maturation. BMC Neuroscience 2010, 11:14.
191. Michelhaugh S.K., Lipovich L., Blythe J., Jia H., Kapatos G., Bannon M.J. Mining Affymetrix microarray data for long non-coding RNAs: altered expression in the nucleus accumbens of heroin abusers. Journal of Neurochemistry 2011, 116(3):459-466.
192. Miller V.M., Xia H., Marrs G.L., Gouvion C.M., Lee G., Davidson B.L., Paulson H.L. Allele-specific silencing of dominant disease genes. Proceedings of the National Academy of Sciences 2003, 100(12):7195-7200.
193. Minones-Moyano E., Porta S., Escaramis G., Rabionet R., Iraola S., Kagerbauer B., Espinosa-Parrilla Y., Ferrer I., Estivill X., Marti E. MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Human Molecular Genetics 2011, 20(15):3067-3078.
194. Modarresi F., Faghihi M.A., Patel N.S., Sahagan B.G., Wahlestedt C., Lopez-Toledano M.A. Knockdown of BACE1-AS nonprotein-coding transcript modulates beta-amyloid-related hippocampal neurogenesis. International Journal of Alzheimer's Disease 2011, 2011:929042.
195. Molnar A., Schwach F., Studholme D.J., Thuenemann E.C., Baulcombe D.C. miRNAs control gene expression in the single-cell alga Chlamydomonas reinhardtii. Nature 2007, 447(7148):1126-1129.
196. Morfini G.A., Burns M., Binder L.I., Kanaan N.M., LaPointe N., Bosco D.A., Brown R.H., Brown H., Tiwari A., Hayward L., et al. Axonal transport defects in neurodegenerative diseases. Journal of NeuroscienceJournal of Neuroscience 2009, 29(41):12776-12786.
197. Morsch R., Simon W., Coleman P.D. Neurons may live for decades with neurofibrillary tangles. Journal of Neuropathology and Experimental Neurology 1999, 58(2):188-197.
198. Mortazavi A., Williams B.A., McCue K., Schaeffer L., Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nature Methods 2008, 5(7):621-628.
199. Moseley M.L., Zu T., Ikeda Y., Gao W., Mosemiller A.K., Daughters R.S., Chen G., Weatherspoon M.R., Clark H.B., Ebner T.J., et al. Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nature Genetics 2006, 38(7):758-769.
200. Mularoni L., Ledda A., Toll-Riera M., Alba M.M. Natural selection drives the accumulation of amino acid tandem repeats in human proteins. Genome Research 2010, 20(6):745-754.
201. Mus E., Hof P.R., Tiedge H. Dendritic BC200 RNA in aging and in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(25):10679-10684.
202. Muslimov I.A., Banker G., Brosius J., Tiedge H. Activity-dependent regulation of dendritic BC1 RNA in hippocampal neurons in culture. The Journal of Cell Biology 1998, 141(7):1601-1611.
203. Mutsuddi M., Marshall C.M., Benzow K.A., Koob M.D., Rebay I. The spinocerebellar ataxia 8 noncoding RNA causes neurodegeneration and associates with staufen in Drosophila. Current Biology: CB 2004, 14(4):302-308.
204. Nagalakshmi U., Wang Z., Waern K., Shou C., Raha D., Gerstein M., Snyder M. The transcriptional landscape of the yeast genome defined by RNA sequencing. Science (New York, NY) 2008, 320(5881):1344-1349.
205. Nemes J.P., Benzow K.A., Moseley M.L., Ranum L.P., Koob M.D. The SCA8 transcript is an antisense RNA to a brain-specific transcript encoding a novel actin-binding protein (KLHL1). Human Molecular Genetics 2000, 9(10):1543-1551.
206. Ng S.Y., Johnson R., Stanton L.W. Human long non-coding RNAs promote pluripotency and neuronal differentiation by association with chromatin modifiers and transcription factors. The EMBO Journal 2012, 31(3):522-533.
207. Nijholt D.A., De Kimpe L., Elfrink H.L., Hoozemans J.J., Scheper W. Removing protein aggregates: the role of proteolysis in neurodegeneration. Current Medicine Chemistry 2011, 18(16):2459-2476.
208. Nishi M., Hashimoto K., Kuriyama K., Komazaki S., Kano M., Shibata S., Takeshima H. Motor discoordination in mutant mice lacking junctophilin type 3. Biochemical and Biophysical Research Communications 2002, 292(2):318-324.
209. Nousiainen H.O., Kestila M., Pakkasjarvi N., Honkala H., Kuure S., Tallila J., Vuopala K., Ignatius J., Herva R., Peltonen L. Mutations in mRNA export mediator GLE1 result in a fetal motoneuron disease. Nature Genetics 2008, 40(2):155-157.
210. Novoyatleva T., Tang Y., Rafalska I., Stamm S. Pre-mRNA missplicing as a cause of human disease. Alternative Splicing and Disease 2006, vol. 44. Ipl., Berlin, Heidelberg.
211. Nudelman A.S., DiRocco D.P., Lambert T.J., Garelick M.G., Le J., Nathanson N.M., Storm D.R. Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo. Hippocampus 2010, 20(4):492-498.
212. Orengo J.P., Chambon P., Metzger D., Mosier D.R., Snipes G.J., Cooper T.A. Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(7):2646-2651.
213. Orom U.A., Derrien T., Beringer M., Gumireddy K., Gardini A., Bussotti G., Lai F., Zytnicki M., Notredame C., Huang Q., et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 2010, 143(1):46-58.
214. Packer A.N., Xing Y., Harper S.Q., Jones L., Davidson B.L. The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. Journal of Neuroscience 2008, 28(53):14341-14346.
215. Pang K.C., Frith M.C., Mattick J.S. Rapid evolution of noncoding RNAs: lack of conservation does not mean lack of function. Trends in Genetics: TIG 2006, 22(1):1-5.
216. Parihar M.S., Parihar A., Fujita M., Hashimoto M., Ghafourifar P. Mitochondrial association of alpha-synuclein causes oxidative stress. Cellular and Molecular Life Sciences 2008, 65(7-8):1272-1284.
217. Perez-Cano L., Solernou A., Pons C., Fernandez-Recio J. Structural prediction of protein-RNA interaction by computational docking with propensity-based statistical potentials. Pacific Symposium on Biocomputing 2010, 293-301.
218. Pollard K.S., Salama S.R., Lambert N., Lambot M.A., Coppens S., Pedersen J.S., Katzman S., King B., Onodera C., Siepel A., et al. An RNA gene expressed during cortical development evolved rapidly in humans. Nature 2006, 443(7108):167-172.
219. Ponjavic J., Oliver P.L., Lunter G., Ponting C.P. Genomic and transcriptional co-localization of protein-coding and long non-coding RNA pairs in the developing brain. PLoS Genetics 2009, 5(8):e1000617.
220. Ponjavic J., Ponting C.P. The long and the short of RNA maps. BioEssays: News and Reviews in Molecular Cellular and Developmental Biology 2007, 29(11):1077-1080.
221. Ponting C.P., Oliver P.L., Reik W. Evolution and functions of long noncoding RNAs. Cell 2009, 136(4):629-641.
222. Pruunsild P., Kazantseva A., Aid T., Palm K., Timmusk T. Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 2007, 90(3):397-406.
223. Pushechnikov A., Lee M.M., Childs-Disney J.L., Sobczak K., French J.M., Thornton C.A., Disney M.D. Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3. Journal of the American Chemical Society 2009, 131(28):9767-9779.
224. Querido E., Gallardo F., Beaudoin M., Menard C., Chartrand P. Stochastic and reversible aggregation of mRNA with expanded CUG-triplet repeats. Journal of Cell Science 2011, 124(Pt 10):1703-1714.
225. Rademakers R., Hutton M. The genetics of frontotemporal lobar degeneration. Current Neurology and Neuroscience Reports 2007, 7(5):434-442.
226. Raghavan R., Groisman E.A., Ochman H. Genome-wide detection of novel regulatory RNAs in E. coli. Genome Research 2011, 21(9):1487-1497.
227. Rajasethupathy P., Fiumara F., Sheridan R., Betel D., Puthanveettil S.V., Russo J.J., Sander C., Tuschl T., Kandel E. Characterization of small RNAs in Aplysia reveals a role for miR-124 in constraining synaptic plasticity through CREB. Neuron 2009, 63(6):803-817.
228. Ranum L.P., Rasmussen P.F., Benzow K.A., Koob M.D., Day J.W. Genetic mapping of a second myotonic dystrophy locus. Nature Genetics 1998, 19(2):196-198.
229. Rapicavoli N.A., Poth E.M., Blackshaw S. The long noncoding RNA RNCR2 directs mouse retinal cell specification. BMC Developmental Biology 2010, 10:49.
230. Rodriguez-Martin T., Garcia-Blanco M.A., Mansfield S.G., Grover A.C., Hutton M., Yu Q., Zhou J., Anderton B.H., Gallo J.M. Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(43):15659-15664.
231. Ross C.A., Poirier M.A. Opinion: What is the role of protein aggregation in neurodegeneration?. Nature Reviews Molecular Cell Biology 2005, 6(11):891-898.
232. Ross C.A., Tabrizi S.J. Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurology 2011, 10(1):83-98.
233. Sahoo T., del Gaudio D., German J.R., Shinawi M., Peters S.U., Person R.E., Garnica A., Cheung S.W., Beaudet A.L. Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nature Genetics 2008, 40(6):719-721.
234. Santacruz K., Lewis J., Spires T., Paulson J., Kotilinek L., Ingelsson M., Guimaraes A., DeTure M., Ramsden M., McGowan E., et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005, 309(5733):476-481.
235. Satoh J. MicroRNAs and their therapeutic potential for human diseases: aberrant microRNA expression in Alzheimer's disease brains. Journal of Pharmacological Sciences 2010, 114(3):269-275.
236. Schaaf C.P., Wiszniewska J., Beaudet A.L. Copy number and SNP arrays in clinical diagnostics. Annual Review of Genomics and Human Genetics 2010.
237. Schaefer A., O'Carroll D., Tan C.L., Hillman D., Sugimori M., Llinas R., Greengard P. Cerebellar neurodegeneration in the absence of microRNAs. Journal of Experimental Medicine 2007, 204(7):1553-1558.
238. Scherzer C.R. Chipping away at diagnostics for neurodegenerative diseases. Neurobiology of Disease 2009, 35(2):148-156.
239. Scherzer C.R., Eklund A.C., Morse L.J., Liao Z., Locascio J.J., Fefer D., Schwarzschild M.A., Schlossmacher M.G., Hauser M.A., Vance J.M., et al. Molecular markers of early Parkinson's disease based on gene expression in blood. Proceedings of the National Academy of Sciences 2007, 104(3):955-960.
240. Schmitt I., Linden M., Khazneh H., Evert B.O., Breuer P., Klockgether T., Wuellner U. Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination. Biochemical and Biophysical Research Communications 2007, 362(3):734-739.
241. Schmitz K.M., Mayer C., Postepska A., Grummt I. Interaction of noncoding RNA with the rDNA promoter mediates recruitment of DNMT3b and silencing of rRNA genes. Genes & Development 2010, 24(20):2264-2269.
242. Schon E.A., Przedborski S. Mitochondria: the next (neurode)generation. Neuron 2011, 70(6):1033-1053.
243. Schratt G.M., Tuebing F., Nigh E.A., Kane C.G., Sabatini M.E., Kiebler M., Greenberg M.E. A brain-specific microRNA regulates dendritic spine development. Nature 2006, 439(7074):283-289.
244. Sempere L.F., Freemantle S., Pitha-Rowe I., Moss E., Dmitrovsky E., Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biology 2004, 5(3):R13.
245. Shen Y., An Y., Wu B.-L. Standardization and diversification of copy number microarray testing for clinical diagnostics-implications of the cross-platform/algorithm study on clinical diagnostic chromosomal microarray analysis. Clinical Chemistry 2011.
246. Shi Y., Noll M. Determination of cell fates in the R7 equivalence group of the Drosophila eye by the concerted regulation of D-Pax2 and TTK88. Developmental Biology 2009, 331(1):68-77.
247. Shibata M., Nakao H., Kiyonari H., Abe T., Aizawa S. MicroRNA-9 regulates neurogenesis in mouse telencephalon by targeting multiple transcription factors. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2011, 31(9):3407-3422.
248. Shimoni Y., Friedlander G., Hetzroni G., Niv G., Altuvia S., Biham O., Margalit H. Regulation of gene expression by small non-coding RNAs: a quantitative view. Molecular Systems Biology 2007, 3:138.
249. Shirendeb U., Reddy A.P., Manczak M., Calkins M.J., Mao P., Tagle D.A., Reddy P.H. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. Human Molecular Genetics 2011, 20(7):1438-1455.
250. Siegel G., Obernosterer G., Fiore R., Oehmen M., Bicker S., Christensen M., Khudayberdiev S., Leuschner P.F., Busch C.J., Kane C., et al. A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nature Cell Biology 2009, 11(6):705-716.
251. Silvestri G., Mongini T., Odoardi F., Modoni A., deRosa G., Doriguzzi C., Palmucci L., Tonali P., Servidei S. A new mtDNA mutation associated with a progressive encephalopathy and cytochrome c oxidase deficiency. Neurology 2000, 54(8):1693-1696.
252. Simard A.R., Soulet D., Gowing G., Julien J.P., Rivest S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 2006, 49(4):489-502.
253. Simon-Sanchez J., Schulte C., Bras J.M., Sharma M., Gibbs J.R., Berg D., Paisan-Ruiz C., Lichtner P., Scholz S.W., Hernandez D.G., et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nature Genetics 2009, 41(12):1308-1312.
254. Sledz C.A., Holko M., de Veer M.J., Silverman R.H., Williams B.R.G. Activation of the interferon system by short-interfering RNAs. Nature Cell Biology 2003, 5(9):834-839.
255. Small D.H. Dysregulation of calcium homeostasis in Alzheimer's disease. Neurochemical Research 2009, 34(10):1824-1829.
256. Smirnova L., Grafe A., Seiler A., Schumacher S., Nitsch R., Wulczyn F.G. Regulation of miRNA expression during neural cell specification. The European Journal of Neuroscience 2005, 21(6):1469-1477.
257. Smith A.D., Xuan Z., Zhang M.Q. Using quality scores and longer reads improves accuracy of Solexa read mapping. BMC Bioinformatics 2008, 9:128.
258. Sobczak K., de Mezer M., Michlewski G., Krol J., Krzyzosiak W.J. RNA structure of trinucleotide repeats associated with human neurological diseases. Nucleic Acids Research 2003, 31(19):5469-5482.
259. Sone M., Hayashi T., Tarui H., Agata K., Takeichi M., Nakagawa S. The mRNA-like noncoding RNA Gomafu constitutes a novel nuclear domain in a subset of neurons. Journal of Cell Science 2007, 120(Pt 15):2498-2506.
260. Sopher B.L., Ladd P.D., Pineda V.V., Libby R.T., Sunkin S.M., Hurley J.B., Thienes C.P., Gaasterland T., Filippova G.N., La Spada A.R. CTCF regulates ataxin-7 expression through promotion of a convergently transcribed, antisense noncoding RNA. Neuron 2011, 70(6):1071-1084.
261. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008, 319(5870):1668-1672.
262. Strong M.J., Volkening K., Hammond R., Yang W., Strong W., Leystra-Lantz C., Shoesmith C. TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Molecular Cell Neuroscience 2007, 35(2):320-327.
263. Sunwoo H., Dinger M.E., Wilusz J.E., Amaral P.P., Mattick J.S., Spector D.L. MEN epsilon/beta nuclear-retained non-coding RNAs are up-regulated upon muscle differentiation and are essential components of paraspeckles. Genome Research 2009, 19(3):347-359.
264. Sutcliffe J.G., Milner R.J., Bloom F.E., Lerner R.A. Common 82-nucleotide sequence unique to brain RNA. Proceedings of the National Academy of Sciences of the United States of America 1982, 79(16):4942-4946.
265. Sutherland H.F., Wadey R., McKie J.M., Taylor C., Atif U., Johnstone K.A., Halford S., Kim U.J., Goodship J., Baldini A., et al. Identification of a novel transcript disrupted by a balanced translocation associated with DiGeorge syndrome. American Journal of Human Genetics 1996, 59(1):23-31.
266. Tang H., Arnold R.J., Alves P., Xun Z., Clemmer D.E., Novotny M.V., Reilly J.P., Radivojac P. A computational approach toward label-free protein quantification using predicted peptide detectability. Bioinformatics (Oxford, England) 2006, 22(14):e481-e488.
267. Tochitani S., Hayashizaki Y. Nkx2.2 antisense RNA overexpression enhanced oligodendrocytic differentiation. Biochemical and Biophysical Research Communications 2008, 372(4):691-696.
268. Todd P.K., Paulson H.L. RNA-mediated neurodegeneration in repeat expansion disorders. Annals of Neurology 2010, 67(3):291-300.
269. Uhde C.W., Vives J., Jaeger I., Li M. Rmst is a novel marker for the mouse ventral mesencephalic floor plate and the anterior dorsal midline cells. PLoS One 2010, 5(1):e8641.
270. Usuki F., Yamashita A., Kashima I., Higuchi I., Osame M., Ohno S. Specific inhibition of nonsense-mediated mRNA decay components, SMG-1 or Upf1, rescues the phenotype of Ullrich disease fibroblasts. Molecular Therapy: The Journal of the American Society of Gene Therapy 2006, 14(3):351-360.
271. Van Damme P., Dewil M., Robberecht W., Van Den Bosch L. Excitotoxicity and amyotrophic lateral sclerosis. Neurodegenerative Diseases 2005, 2(3-4):147-159.
272. van Deutekom J.C., Janson A.A., Ginjaar I.B., Frankhuizen W.S., Aartsma-Rus A., Bremmer-Bout M., den Dunnen J.T., Koop K., van der Kooi A.J., Goemans N.M., et al. Local dystrophin restoration with antisense oligonucleotide PRO051. The New England Journal of Medicine 2007, 357(26):2677-2686.
273. van Eyk C.L., McLeod C.J., O'Keefe L.V., Richards R.I. Comparative toxicity of polyglutamine, polyalanine and polyleucine tracts in Drosophila models of expanded repeat disease. Human Molecular Genetics 2012, 21(3):536-547.
274. Vance C., Rogelj B., Hortobagyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009, 323(5918):1208-1211.
275. Verkerk A.J., Pieretti M., Sutcliffe J.S., Fu Y.H., Kuhl D.P., Pizzuti A., Reiner O., Richards S., Victoria M.F., Zhang F.P., et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991, 65(5):905-914.
276. Vidal R., Caballero B., Couve A., Hetz C. Converging pathways in the occurrence of endoplasmic reticulum (ER) stress in Huntington's disease. Current Molecular Medicine 2011, 11(1):1-12.
277. Visvanathan J., Lee S., Lee B., Lee J.W., Lee S.K. The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes & Development 2007, 21(7):744-749.
278. Vives-Bauza C., Przedborski S. Mitophagy: the latest problem for Parkinson's disease. Trends in Molecular Medicine 2011, 17(3):158-165.
279. Vo N., Klein M.E., Varlamova O., Keller D.M., Yamamoto T., Goodman R.H., Impey S. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(45):16426-16431.
280. Wagner U., Utton M., Gallo J.M., Miller C.C. Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation. Journal of Cell Science 1996, 109(Pt 6):1537-1543.
281. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002, 416(6880):535-539.
282. Wang G., van der Walt J.M., Mayhew G., Li Y.J., Zuchner S., Scott W.K., Martin E.R., Vance J.M. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. American Journal of Human Genetics 2008, 82(2):283-289.
283. Wang H., Iacoangeli A., Lin D., Williams K., Denman R.B., Hellen C.U., Tiedge H. Dendritic BC1 RNA in translational control mechanisms. The Journal of Cell Biology 2005, 171(5):811-821.
284. Wang K.C., Chang H.Y. Molecular mechanisms of long noncoding RNAs. Molecular Cell 2011, 43(6):904-914.
285. Wang W.X., Rajeev B.W., Stromberg A.J., Ren N., Tang G., Huang Q., Rigoutsos I., Nelson P.T. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. Journal of Neuroscience 2008, 28(5):1213-1223.
286. Wang W.X., Rajeev B.W., Stromberg A.J., Ren N., Tang G., Huang Q., Rigoutsos I., Nelson P.T. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. The Journal of Neuroscience 2008, 28(5):1213-1223.
287. Wang Y., Garg S., Mandelkow E.M., Mandelkow E. Proteolytic processing of tau. Biochemical Society Transactions 2010, 38(4):955-961.
288. Wang Z., Gerstein M., Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nature Reviews. Genetics 2009, 10(1):57-63.
289. Warraich S.T., Yang S., Nicholson G.A., Blair I.P. TDP-43: a DNA and RNA binding protein with roles in neurodegenerative diseases. The International Journal of Biochemistry & Cell Biology 2010, 42(10):1606-1609.
290. Waxman E.A., Giasson B.I. Induction of intracellular tau aggregation is promoted by alpha-synuclein seeds and provides novel insights into the hyperphosphorylation of tau. Journal of Neuroscience 2011, 31(21):7604-7618.
291. Welch E.M., Barton E.R., Zhuo J., Tomizawa Y., Friesen W.J., Trifillis P., Paushkin S., Patel M., Trotta C.R., Hwang S., et al. PTC124 targets genetic disorders caused by nonsense mutations. Nature 2007, 447(7140):87-91.
292. Wheeler T.M., Sobczak K., Lueck J.D., Osborne R.J., Lin X., Dirksen R.T., Thornton C.A. Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science 2009, 325(5938):336-339.
293. White M., Xia G., Gao R., Wakamiya M., Sarkar P.S., McFarland K., Ashizawa T. Transgenic mice with SCA10 pentanucleotide repeats show motor phenotype and susceptibility to seizure: a toxic RNA gain-of-function model. Journal of Neuroscience Research 2012, 90(3):706-714.
294. Wilburn B., Rudnicki D.D., Zhao J., Weitz T.M., Cheng Y., Gu X., Greiner E., Park C.S., Wang N., Sopher B.L., et al. An antisense CAG repeat transcript at JPH3 locus mediates expanded polyglutamine protein toxicity in Huntington's disease-like 2 mice. Neuron 2011, 70(3):427-440.
295. Wilhelm B.T., Marguerat S., Watt S., Schubert F., Wood V., Goodhead I., Penkett C.J., Rogers J., Bähler J.R. Dynamic repertoire of a eukaryotic transcriptome surveyed at single-nucleotide resolution. Nature 2008, 453(7199):1239-1243.
296. Williams A.H., Valdez G., Moresi V., Qi X., McAnally J., Elliott J.L., Bassel-Duby R., Sanes J.R., Olson E.N. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 2009, 326(5959):1549-1554.
297. Willingham A.T., Orth A.P., Batalov S., Peters E.C., Wen B.G., Aza-Blanc P., Hogenesch J.B., Schultz P.G. A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science 2005, 309(5740):1570-1573.
298. Wojciechowska M., Krzyzosiak W.J. Cellular toxicity of expanded RNA repeats: focus on RNA foci. Human Molecular Genetics 2011, 20(19):3811-3821.
299. Wray S., Lewis P.A. A tangled web-tau and sporadic Parkinson's disease. Front Psychiatry 2010, 1:150.
300. Wright J.M., Merlo C.A., Reynolds J.B., Zeitlin P.L., Garcia J.G.N., Guggino W.B., Boyle M.P. Respiratory Epithelial Gene Expression in Patients with Mild and Severe Cystic Fibrosis Lung Disease. American Journal of Respiratory Cell and Molecular Biology 2006, 35(3):327-336.
301. Wu T., Wang J., Liu C., Zhang Y., Shi B., Zhu X., Zhang Z., Skogerbo G., Chen L., Lu H., et al. NPInter: the noncoding RNAs and protein related biomacromolecules interaction database. Nucleic Acids Research 2006, 34(Database issue):D150-D152.
302. Xiang C.C., Chen M., Ma L., Phan Q.N., Inman J.M., Kozhich O.A., Brownstein M.J. A new strategy to amplify degraded RNA from small tissue samples for microarray studies. Nucleic Acids Research 2003, 31(9):e53.
303. Yang F., Zhang L., Huo X.-S., Yuan J.-H., Xu D., Yuan S.-X., Zhu N., Zhou W.-P., Yang G.-S., Wang Y.-Z., et al. Long non-coding RNA high expressed in hepatocellular carcinoma (lncRNA-HEIH) facilitates tumor growth through enhancer of zeste homolog 2. Hepatology (Baltimore, MD) 2011.
304. Yoo A.S., Staahl B.T., Chen L., Crabtree G.R. MicroRNA-mediated switching of chromatin-remodelling complexes in neural development. Nature 2009, 460(7255):642-646.
305. Yoo A.S., Sun A.X., Li L., Shcheglovitov A., Portmann T., Li Y., Lee-Messer C., Dolmetsch R.E., Tsien R.W., Crabtree G.R. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature 2011, 476(7359):228-231.
306. Yu Z., Teng X., Bonini N.M. Triplet repeat-derived siRNAs enhance RNA-mediated toxicity in a Drosophila model for myotonic dystrophy. PLoS Genetics 2011, 7(3):e1001340.
307. Zalfa F., Adinolfi S., Napoli I., Kuhn-Holsken E., Urlaub H., Achsel T., Pastore A., Bagni C. Fragile X mental retardation protein (FMRP) binds specifically to the brain cytoplasmic RNAs BC1/BC200 via a novel RNA-binding motif. The Journal of Biological Chemistry 2005, 280(39):33403-33410.
308. Zhang M., Wang Q., Huang Y. Fragile X mental retardation protein FMRP and the RNA export factor NXF2 associate with and destabilize Nxf1 mRNA in neuronal cells. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(24):10057-10062.
309. Zhang Q., Yu J.T., Wang P., Chen W., Wu Z.C., Jiang H., Tan L. Mitochondrial transcription factor A (TFAM) polymorphisms and risk of late-onset Alzheimer's disease in Han Chinese. Brain Reserach 2011, 1368:355-360.
310. Zhang Y.J., Xu Y.F., Cook C., Gendron T.F., Roettges P., Link C.D., Lin W.L., Tong J., Castanedes-Casey M., Ash P., et al. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(18):7607-7612.
311. Zheng B., Liao Z., Locascio J.J., Lesniak K.A., Roderick S.S., Watt M.L., Eklund A.C., Zhang-James Y., Kim P.D., Hauser M.A., et al. PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease. Science Translational Medicine 2010, 2(52). 52ra73.
312. Zhong J., Chuang S.C., Bianchi R., Zhao W., Lee H., Fenton A.A., Wong R.K., Tiedge H. BC1 regulation of metabotropic glutamate receptor-mediated neuronal excitability. The Journal of Neuroscience 2009, 29(32):9977-9986.
313. Zhong J., Chuang S.C., Bianchi R., Zhao W., Paul G., Thakkar P., Liu D., Fenton A.A., Wong R.K., Tiedge H. Regulatory BC1 RNA and the fragile X mental retardation protein: convergent functionality in brain. PLoS One 2010, 5(11):e15509.
314. Zhou Y., Zhong Y., Wang Y., Zhang X., Batista D.L., Gejman R., Ansell P.J., Zhao J., Weng C., Klibanski A. Activation of p53 by MEG3 non-coding RNA. The Journal of Biological Chemistry 2007, 282(34):24731-24742.
315. Zu T., Gibbens B., Doty N.S., Gomes-Pereira M., Huguet A., Stone M.D., Margolis J., Peterson M., Markowski T.W., Ingram M.A., et al. Non-ATG-initiated translation directed by microsatellite expansions. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(1):260-265.